American Association of Clinical Endocrinologists and American College of Endocrinology Guidelines for Management of Dyslipidemia and Prevention of Cardiovascular Disease

Developed by the American College of Cardiology/American Heart Association task force on practice guidelines in collaboration with the National Heart, Lung, and Blood Institute (NHLBI) in an effort to provide guidelines for the assessment of cardiovascular (CV) risk to promote optimal CV health and prevent CV disease, the objective of this publication was to develop an approach to quantify risk assessment in order to guide care and to address key clinical questions surrounding the assessment of CV risk targeting asymptomatic patients in the general population; i.e. those with no history of atherosclerotic cardiovascular disease (ASCVD).